Research that is free to access for all investors. Companies commission these providers to write research about them.
Brokers who write research on their corporate clients and make it available through our main bundle offering.
Research that is paid for directly by asset managers. Only accessible to institutional investors permissioned for access.
Event in Progress:
Vadim Alexandre | Liam Gascoigne-Cohen
3 pages
Motif Bio (MTFB.L): Further clinical trial data required for iclaprim approval | Collagen Solutions (COS.L): Result of General Meeting and Open Offer
Companies: Vimian Group AB
Companies: Arrowhead Pharmaceuticals Inc (ARWR:NYSE)Arrowhead Pharmaceuticals, Inc. (ARWR:NAS)
Companies: Cinclus Pharma Holding AB
Companies: TuHURA Biosciences, Inc.
Companies: Soligenix Inc (SNGX:NYSE)Soligenix, Inc. (SNGX:NAS)
